Material Agreements

SUJA LIFE, INC. amended Fifth Amendment to the Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent (effective 2026-05-08).

“On May 8, 2026, certain indirect subsidiaries of the Company entered into that certain Fifth Amendment to the Credit Agreement (the “Amendment”) which amended that certain Credit Agreement, dated as of August 23, 2021, by and among Suja Life Intermediate II, LLC, Suja Life, LLC, JPMorgan Chase Bank, N.A., as administrative agent, the guarantors party thereto from time to time and the lenders party thereto from time to time (as amended, restated, amended and restated, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”)”

SUJA LIFE, INC. entered into Underwriting Agreement with Goldman Sachs & Co. LLC, Jefferies LLC, and William Blair & Company, L.L.C., as representatives of the several underwriters valued at 8,888,889 shares of Class A Common Stock at a public offering price of $21.00 per share (effective 2026-05-06).

“On May 6, 2026, Suja Life, Inc. (the “Company”) and Suja Life Holdings, L.P. (“Holdings LP”) entered into an underwriting agreement (the “Underwriting Agreement”) with Goldman Sachs & Co. LLC, Jefferies LLC, and William Blair & Company, L.L.C., as representatives of the several underwriters named therein (collectively, the “Underwriters”) relating to the initial public offering (the “IPO”) of the Company’s Class A common stock”

Quetta Acquisition Corp terminated Release and Discharge of Promissory Notes with KM Quad valued at $1,040,000 (effective 2026-04-30).

“On April 30, 2026, Quetta Acquisition Corporation (the “Company”) entered into that certain Release and Discharge of Promissory Notes (the “Release”) with KM Quad, a Cayman Islands exempted company (“KM Quad”).”

MEDICAL EXERCISE INC. entered into Franchise Agreement with Degco Fitness Ventures Ltd. (effective 2026-05-06).

“On May 6, 2026, Medical Exercise Inc. (the “Company”) entered into a Franchise Agreement (the “Agreement”) with Degco Fitness Ventures Ltd., a corporation based in Regina, Saskatchewan, Canada.”

MEDICAL EXERCISE INC. entered into Franchise Agreement with Degco Fitness Ventures Ltd. (effective 2026-05-06).

“On May 6, 2026, Medical Exercise Inc. (the “Company”) entered into a Franchise Agreement (the “Agreement”) with Degco Fitness Ventures Ltd., a corporation based in Regina, Saskatchewan, Canada.”

21Shares Polkadot ETF entered into Figment Agreement with Figment Inc. (effective 2026-05-04).

“On May 4, 2026, 21Shares Polkadot ETF (the “Trust”) entered into a staking services agreement with Figment Inc., an Ontario corporation (“Figment” and such agreement, the “Figment Agreement”),”

PERMIAN BASIN ROYALTY TRUST amended Amendment No. 2 to the Amended and Restated Trust Indenture of Permian Basin Royalty Trust (effective 2026-05-08).

“Argent Trust Company, the trustee of the Trust, entered into Amendment No. 2 to the Amended and Restated Trust Indenture of Permian Basin Royalty Trust dated May 8, 2026 (the “Amendment”) implementing the modifications approved by the Court.”

NextTrip, Inc. entered into Purchase Agreement with an accredited investor (effective 2026-05-06).

“On May 6, 2026, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with an accredited investor (the “Purchaser”), pursuant to which the Company issued and sold (a) an aggregate of 368,421 restricted shares of newly designated Series B Convertible Preferred Stock, par value $0.001, of the Company (the “Series B Preferred Shares”) plus 40,000 additional Series B Preferred Shares as an issuance fee; and (b) a five-year warrant (the “Warrant”) to purchase 100,000 shares of the Common Stock, par value $0.001 per share, of the Company (“Common Stock”) (the “Series B Offering”) at a purchase price of $2.7550 per share representing the Nasdaq Minimum Price plus $0.125 as of the date of the Purchase Agreement.”

IMMUCELL CORP /DE/ entered into Settlement Deed with Norbrook Laboratories Limited valued at $2,000,000 (effective 2026-05-08).

“On May 8, 2026, ImmuCell Corporation and Norbrook Laboratories Limited (incorporated and registered in Northern Ireland) entered into a Settlement Deed to resolve and release any and all claims arising out of or relating to an underlying 2019 Development Services and Commercial Supply Agreement between the two companies.”

AZZ INC amended Seventh Amendment to Credit Agreement with Wells Fargo Bank, N.A. valued at Amendment of Credit Agreement dated May 13, 2022; terminated Initial Revolving Credit Commitments, r (effective 2026-05-07).

“On May 7, 2026, AZZ Inc. (the " Company ") entered into the Seventh Amendment to its existing Credit Agreement referenced below with Wells Fargo Bank, N.A. (“ Wells Fargo ”), as Administrative Agent and Collateral Agent and the requisite lenders (the " Seventh Amendment" ).”

CANTALOUPE, INC. terminated Credit Agreement with JPMorgan Chase Bank, N.A..

“the Company terminated and repaid in full all outstanding obligations due under the Second Amended and Restated Credit Agreement, dated as of January 31, 2025, by and among, inter alios , the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “ Credit Agreement ”).”

NEKTAR THERAPEUTICS entered into Equity Distribution Agreement with Guggenheim Securities, LLC and H.C. Wainwright & Co., LLC valued at $150,000,000 (effective 2026-05-08).

“On May 8, 2026, Nektar Therapeutics (the “Company”) entered into an Equity Distribution Agreement (the “Agreement”) with Guggenheim Securities, LLC (“Guggenheim Securities”) and H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which the Company may offer and sell, from time to time in its sole discretion, shares of its common stock, par value $0.0001 per share (the “Common Stock”) having an aggregate offering price of up to $150,000,000 (the “Shares”), through Guggenheim Securities and Wainwright as its sales agents.”

AIM ImmunoTech Inc. entered into Engagement Agreement with Ladenburg Thalmann & Co. Inc. (effective 2026-05-07).

“The Company entered into an engagement agreement (the “Engagement Agreement”) with Ladenburg Thalmann & Co. Inc. (the “Placement Agent”) to act as its placement agent in connection with the transactions summarized above.”

AIM ImmunoTech Inc. entered into Inducement Letter with holders of Existing May 2024 Warrants, Existing September 2024 Warrants, and Existing July 2025 Warrants valued at approximately $4.20 million (effective 2026-05-07).

“On May 7, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a warrant exercise inducement offer letter agreement (the “Inducement Letter”) with holders (the “Holders”) of (i) Class A and Class B common stock purchase warrants issued on May 31, 2024”

VSE CORP amended First Amendment with Citizens Bank, N.A., as revolver administrative agent and collateral agent, and Royal Bank of Canada, as term loan B agent valued at $900.0 million (effective 2026-05-05).

“On May 5, 2026, the Company, as the borrower, and its domestic wholly owned subsidiaries, as guarantors (collectively, together with the Company, the “Loan Parties”), entered into a first amendment (the “First Amendment”) to its existing senior secured credit agreement, dated as of May 2, 2025 (as amended and restated, supplemented or otherwise modified, the “Credit Agreement”), with certain banks and financial institutions as lenders (the “Lenders”), Citizens Bank, N.A., as revolver administrative agent and collateral agent, and Royal Bank of Canada, as term loan B agent”

VSE CORP entered into Lock-Up Agreements with Seller (effective 2026-05-05).

“On May 5, 2026, in connection with the Closing, VSE and Seller entered into (i) a lock-up agreement covering the shares to be issued to Seller pursuant to the Exchange Agreement (the “Closing Lock-Up Agreement”) and (ii) a lock-up agreement covering any shares to be issued to Seller pursuant to the Purchase Agreement as an Earnout Payment (as defined herein) (the “Earnout Lock-Up Agreement””

VSE CORP entered into Registration Rights Agreement with Seller (effective 2026-05-05).

“On May 5, 2026, in connection with the Closing, VSE and Seller entered into a registration rights agreement (the “Registration Rights Agreement”)”

VSE CORP entered into Exchange Agreement with Rollover Purchaser and Seller (effective 2026-05-05).

“On May 5, 2026, in connection with the Closing, VSE, Rollover Purchaser and Seller entered into an exchange and redemption agreement (the “Exchange Agreement”)”

AMERICAN TOWER CORP /MA/ amended 2021 Term Loan with Mizuho Bank, Ltd. valued at Extended maturity to May 1, 2029; amended lien and indebtedness covenants (effective 2026-05-07).

“On May 7, 2026, American Tower Corporation (the “Company”) entered into three separate amendment agreements (each an “Amendment” and collectively, the “Amendments”) to amend the agreements for each of its (i) $6.0 billion senior unsecured multicurrency revolving credit facility, as amended and restated on December 8, 2021, as further amended, with Toronto Dominion (Texas) LLC (“TD”) as Administrative Agent (as defined therein) (the “2021 Multicurrency Credit Facility”), (ii) $4.0 billion senior unsecured revolving credit facility, as amended and restated on December 8, 2021, as further amended, with TD as Administrative Agent (as defined therein) (the “2021 Credit Facility”) and (iii) $1.0 billion unsecured term loan, as amended and restated on December 8, 2021, as further amended, with Mizuho Bank, Ltd. as Administrative Agent (as defined therein) (the “2021 Term Loan” and, collectively with the 2021 Multicurrency Credit Facility and the 2021 Credit Facility, the “Loans”).”

AMERICAN TOWER CORP /MA/ amended 2021 Credit Facility with Toronto Dominion (Texas) LLC valued at Extended maturity to May 1, 2031; increased swingline sublimit to $100.0 million; amended lien and i (effective 2026-05-07).

“On May 7, 2026, American Tower Corporation (the “Company”) entered into three separate amendment agreements (each an “Amendment” and collectively, the “Amendments”) to amend the agreements for each of its (i) $6.0 billion senior unsecured multicurrency revolving credit facility, as amended and restated on December 8, 2021, as further amended, with Toronto Dominion (Texas) LLC (“TD”) as Administrative Agent (as defined therein) (the “2021 Multicurrency Credit Facility”), (ii) $4.0 billion senior unsecured revolving credit facility, as amended and restated on December 8, 2021, as further amended, with TD as Administrative Agent (as defined therein) (the “2021 Credit Facility”) and (iii) $1.0 billion unsecured term loan, as amended and restated on December 8, 2021, as further amended, with Mizuho Bank, Ltd. as Administrative Agent (as defined therein) (the “2021 Term Loan” and, collectively with the 2021 Multicurrency Credit Facility and the 2021 Credit Facility, the “Loans”).”

AMERICAN TOWER CORP /MA/ amended 2021 Multicurrency Credit Facility with Toronto Dominion (Texas) LLC valued at Extended maturity to May 1, 2029; increased swingline sublimit to $100.0 million; amended lien and i (effective 2026-05-07).

“On May 7, 2026, American Tower Corporation (the “Company”) entered into three separate amendment agreements (each an “Amendment” and collectively, the “Amendments”) to amend the agreements for each of its (i) $6.0 billion senior unsecured multicurrency revolving credit facility, as amended and restated on December 8, 2021, as further amended, with Toronto Dominion (Texas) LLC (“TD”) as Administrative Agent (as defined therein) (the “2021 Multicurrency Credit Facility”), (ii) $4.0 billion senior unsecured revolving credit facility, as amended and restated on December 8, 2021, as further amended, with TD as Administrative Agent (as defined therein) (the “2021 Credit Facility”) and (iii) $1.0 billion unsecured term loan, as amended and restated on December 8, 2021, as further amended, with Mizuho Bank, Ltd. as Administrative Agent (as defined therein) (the “2021 Term Loan” and, collectively with the 2021 Multicurrency Credit Facility and the 2021 Credit Facility, the “Loans”).”

Booking Holdings Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $750,000,000 aggregate principal amount (effective 2026-05-07).

“Booking Holdings Inc. (the “ Company ”) executed an Officers’ Certificate (the “ Officers’ Certificate ”), in accordance with Sections 2.02 and 10.04 of the Indenture dated August 8, 2017 (the “ Base Indenture ” and, together with the Officers’ Certificate, the “ Indenture ”) between the Company and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee (the “ Trustee ”) and registrar, in connection with the sale of $750,000,000 aggregate principal amount of the Company’s 5.375% Senior Notes due 2036 (the “ Senior Notes ”).”

WORLD OMNI AUTO RECEIVABLES LLC entered into Underwriting Agreement with BofA Securities, Inc., Mizuho Securities USA LLC, Truist Securities, Inc. and U.S. Bancorp Investments, Inc., on behalf of themselves and as representatives of the several underwriters valued at $1,296,630,000 aggregate principal balance (effective 2026-05-05).

“On May 5, 2026, World Omni Financial Corp. (“World Omni”) and World Omni Auto Receivables LLC (the “Depositor”) entered into an Underwriting Agreement with BofA Securities, Inc., Mizuho Securities USA LLC, Truist Securities, Inc. and U.S. Bancorp Investments, Inc., on behalf of themselves and as representatives of the several underwriters (collectively, the “Underwriters”), whereby each of the Underwriters has severally agreed to purchase $1,296,630,000 aggregate principal balance of various classes of Asset-Backed Notes to be issued by World Omni Auto Receivables Trust 2026-B”

CROSS COUNTRY HEALTHCARE INC entered into Merger Agreement with KL Criss Cross Intermediate, LLC and KL Criss Cross Merger Sub, Inc. valued at $13.25 in cash (effective 2026-05-06).

“On May 6, 2026, Cross Country Healthcare, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among the Company, KL Criss Cross Intermediate, LLC, a Delaware limited liability company (“ Parent ”), and KL Criss Cross Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), pursuant to which Merger Sub will merge with and into the Company (the “ Merger ”), with the Company surviving as a wholly owned subsidiary of Parent”

ONCOR ELECTRIC DELIVERY CO LLC amended Amendment No. 3 to Receivables Financing Agreement with MUFG Bank, Ltd., as administrative agent, and certain lenders and group agents party thereto valued at $600 million (effective 2026-05-05).

“On May 5, 2026, Oncor Electric Delivery Company LLC (“Oncor”) entered into Amendment No. 3 to Receivables Financing Agreement (the “RFA Amendment”) among Oncor Receivables LLC, as borrower (“Receivables LLC”), Oncor, as servicer, MUFG Bank, Ltd., as administrative agent, and certain lenders and group agents party thereto.”

MERCER INTERNATIONAL INC. amended Waiver and Consent Request Letter with UniCredit Bank GmbH, as agent (effective 2026-05-04).

“Effective May 4, 2026, certain German subsidiaries (the “ Loan Parties ”) of Mercer International Inc. (the “ Company ”) entered into a Waiver and Consent Request Letter (the “ Waiver ”) with respect to that certain revolving facility agreement dated September 15, 2022”

Healthcare Realty Trust Inc entered into Indenture with U.S. Bank Trust Company, National Association, as trustee valued at $700,000,000 aggregate principal amount (effective 2026-05-07).

“The Notes were issued pursuant to, and are governed by, an indenture (the “ Indenture ”), dated as of May 7, 2026, among the Issuer, the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”).”

CATALYST PHARMACEUTICALS, INC. entered into Agreement and Plan of Merger with Angelini Pharma S.p.A. valued at $31.50 per Share in cash (effective 2026-05-06).

“On May 6, 2026, Catalyst Pharmaceuticals, Inc. (“ Catalyst ” or the “ Company ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) with Angelini Pharma S.p.A., an Italian Società per azioni (“ Angelini Pharma ” or “ Parent ”), and Angelini Cielo Inc., a Delaware corporation and wholly-owned subsidiary of Parent (“ Merger Sub ”), providing for the merger of Merger Sub with and into the Company (the “ Merger ”), with the Company surviving the Merger as a wholly-owned subsidiary of Parent.”

Ocugen, Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $115.0 million aggregate principal amount of 6.75% Convertible Senior Notes due 2034 (effective 2026-05-07).

“On May 7, 2026, Ocugen, Inc. (the “Company”) completed its previously announced private offering (the “offering”) of $115.0 million aggregate principal amount of 6.75% Convertible Senior Notes due 2034 (the “notes”). The notes were issued pursuant to an indenture, dated May 7, 2026 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee.”

FOX FACTORY HOLDING CORP amended Sixth Amendment to Credit Agreement and Third Amendment to Guaranty and Security Agreement with Wells Fargo Bank, National Association, as administrative agent, swingline lender and L/C issuer, and a group of lenders (effective 2026-05-06).

“On May 6, 2026, Fox Factory Holding Corp., a Delaware corporation (the “Company”), entered into the Sixth Amendment to Credit Agreement and Third Amendment to Guaranty and Security Agreement (the “Amendment”) among the Company, certain subsidiaries of the Company, Wells Fargo Bank, National Association, as administrative agent, swingline lender and L/C issuer (the “Agent”), and a group of lenders party thereto.”

AMERICOLD REALTY TRUST entered into Contribution Agreement with Snowfall Topco LP, an affiliate of EQT valued at in excess of $1.3 billion (effective 2026-05-07).

“On May 7, 2026, Americold Realty Operating Partnership, LP, a Delaware limited partnership, MHG Gateway Properties, LLC, a New Jersey limited liability company, ART Mortgage Borrower Propco 2010 - 5 LLC, a Delaware limited liability company, Americold New TRS Sub 1, LLC, a Delaware limited liability company, Americold Real Estate, L.P., a Delaware limited partnership, ART Mortgage Borrower Propco 2010 - 4 LLC, a Delaware limited liability company, New Hall’s Warehouse LLC, a New Jersey limited liability company and Americold Russellville, LLC, an Arkansas limited liability company, each a subsidiary of Americold Realty Trust, Inc. (the “ Company ”) and Snowfall Topco LP, an affiliate of EQT entered into a contribution agreement (the “ Contribution Agreement ” and the transactions described therein, the “ JV Transaction ”), which was unanimously approved by the Company’s Board of Directors (the “Board”), upon the unanimous recommendation of the Finance Committee of the Board, to create”

Avalo Therapeutics, Inc. entered into Underwriting Agreement with Leerink Partners LLC, TD Securities (USA) LLC and BofA Securities, Inc., as representatives of the underwriters valued at approximately $405.0 million (effective 2026-05-05).

“On May 5, 2026, Avalo Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Leerink Partners LLC, TD Securities (USA) LLC and BofA Securities, Inc., as representatives of the underwriters listed in Schedule A thereto (the “Underwriters”), pursuant to which the Company agreed to issue and sell an aggregate of (a) 19,730,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”), at a price to the public of $17.75 per Share, and (b) pre-funded warrants to purchase up to 1,400,000 shares of Common Stock (the “Pre-Funded Warrants”), at a price to the public of $17.749 per Pre-Funded Warrant, which represents the per share public offering price for the Shares less the $0.001 per share exercise price for each such Pre-Funded Warrant (the “Offering”).”

Pathfinder Bancorp, Inc. amended Registration Rights Agreement with Castle Creek Capital Partners VII, L.P. (effective 2026-05-04).

“On May 4, 2026, the Company and Castle Creek agreed to amend the Registration Rights Agreement to allow the Company to file a resale registration statement by no later than May 8, 2027 to register the resale of the securities.”

GMF Leasing LLC entered into Underwriting Agreement with Citigroup Global Markets Inc., J.P. Morgan Securities LLC, SG Americas Securities, LLC, TD Securities (USA) LLC, BMO Capital Markets Corp., Credit Agricole Securities (USA) Inc., Lloyds Securities Inc. and Loop Capital Markets LLC valued at $167,180,000 Class A-1 3.831% Asset Backed Notes, $300,000,000 Class A-2-A 4.12% Asset Backed Notes, (effective 2026-05-05).

“GMF Leasing LLC, as depositor (the “ Depositor ”) and AmeriCredit Financial Services, Inc. d/b/a GM Financial (“ GM Financial ”), as sponsor, will cause a newly formed issuing entity, GM Financial Automobile Leasing Trust 2026-2 (the “ Issuing Entity ”), to issue $167,180,000 Class A-1 3.831% Asset Backed Notes (the “ Class A-1 Notes ”), $300,000,000 Class A-2-A 4.12% Asset Backed Notes (the “ Class A-2-A Notes ”), $141,250,000 Class A-2-B Floating Rate Asset Backed Notes (the “ Class A-2-B Notes ”), $441,250,000 Class A-3 4.30% Asset Backed Notes (the “ Class A-3 Notes ”), $82,000,000 Class A-4 4.36% Asset Backed Notes (the “ Class A-4 Notes ” and, together with the Class A-1 Notes, the Class A-2-A Notes, the Class A-2-B Notes and the Class A-3 Notes, the “ Class A Notes ”), $61,800,000 Class B 4.60% Asset Backed Notes (the “ Class B Notes ” and, collectively with the Class A Notes, the “ Publicly Offered Notes ”) and $57,000,000 Class C 4.70% Asset Backed Notes (the “ Class C Notes ””

Alector, Inc. entered into Sales Agreement with TD Securities (USA) LLC valued at up to $125,000,000 (effective 2026-05-07).

“On May 7, 2026, Alector, Inc. (the “ Company ”) entered into a Sales Agreement (the “ Sales Agreement ”) with TD Securities (USA) LLC (“ TD Cowen ”), pursuant to which the Company may offer and sell from time to time through TD Cowen up to $125,000,000 of shares”

ProPetro Holding Corp. entered into Indenture with U.S. Bank Trust Company, National Association valued at $690 million (effective 2026-05-07).

“On May 7, 2026, ProPetro Holding Corp. (the “ Company ”), issued $690 million aggregate principal amount of its 0.00% Convertible Senior Notes due 2031 (the “ Notes ”), which included the exercise in full of the Initial Purchasers’ (as defined below) option to purchase up to an additional $90 million principal amount of Notes. The Notes were issued pursuant to, and are governed by, an indenture (the “ Indenture ”), dated as of May 7, 2026, between the Company and U.S. Bank Trust Company, National Association, as trustee (the “ Trustee ”).”

Liberty Energy Inc. entered into Supply Contracts for Power Generation Equipment with Bergen Engines AS valued at $505,000,000 (effective 2026-05-01).

“On May 1, 2026, Liberty Advanced Equipment Technologies LLC (the “Purchaser”), a wholly owned subsidiary of Liberty Energy Inc. (the “Company”), entered into two supply contracts with Bergen Engines AS (“Bergen”) for the purchase of power generation equipment, including engines and certain balance of plant equipment, for the Company’s prospective data center and other distributed power projects (each, a “Supply Contract” and, collectively, the “Supply Contracts”).”

BT Brands, Inc. terminated Merger Agreement with Aero Velocity Inc. (effective 2026-05-01).

“On May 1, 2026, the Company delivered written notice to Aero terminating the Merger Agreement pursuant to Section 7.1(b) thereof.”

Alset Inc. terminated Termination Agreement Relating to Purchase of Shares of Hapi Metaverse Inc. with HWH International Inc. valued at Termination of purchase and sale of 505,341,376 shares of Hapi Metaverse Inc. common stock for $19,9 (effective 2026-05-06).

“The Company and its subsidiary HWH have now agreed to terminate the purchase and sale of the Hapi Metaverse Shares, and the agreements contemplating the same, on the terms and subject to the conditions set forth in a Termination Agreement dated May 6, 2026.”

Shuttle Pharmaceuticals Holdings, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at Securities Purchase Agreement for issuance of Series B-2 convertible preferred stock and common stoc (effective 2026-04-30).

“on April 30, 2026, the Acquiror entered into a Securities Purchase Agreement (the “ Securities Purchase Agreement ”) with certain accredited investors party thereto (each, a “ Purchaser ” and collectively, the “ Purchasers ”), pursuant to which the Acquiror agreed to issue (i) 1,910 newly designated Series B-2 convertible preferred stock, par value $0.00001 (the “ Series B-2 Preferred Stock ”) and (ii) common stock purchase warrants (the “ Common Warrants ” and together with the Series B-2 Preferred Stock, the “ PIPE Securities ”) to purchase up to 100% of the number of shares of Common Stock underlying the Series B-2 Convertible Preferred Stock as of the Closing Date, exercisable for a period of three (3) years at an exercise price of $1.03 per share (the “ PIPE Financing ”).”

Shuttle Pharmaceuticals Holdings, Inc. entered into Agreement and Plan of Merger with United Dogecoin Inc. valued at Agreement and Plan of Merger entered into on April 30, 2026 by and among Acquiror, Merger Sub and th (effective 2026-04-30).

“On May 6, 2026 (the “ Closing Date ”), Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (“ Shuttle ” or “ Acquiror ”), completed its previously announced merger pursuant to an Agreement and Plan of Merger (the “ Merger Agreement ”), entered into on April 30, 2026 by and among the Acquiror, Shuttle Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Shuttle (“ Merger Sub ”) and United Dogecoin Inc., a Delaware corporation (the “ Company ”).”

Trinity Capital Inc. entered into Sales Agreements with Jefferies LLC, B. Riley Securities, Inc., Keefe, Bruyette & Woods, Inc., Compass Point Research & Trading, LLC valued at up to $300,000,000 (effective 2026-05-07).

“On May 7, 2026, Trinity Capital Inc. (the “Company”) entered into (i) an open market sale agreement with Jefferies LLC (“Jefferies”), as sales agent and/or principal thereunder, (ii) an open market sale agreement with B. Riley Securities, Inc. (“B. Riley”), as sales agent and/or principal thereunder, (iii) an open market sale agreement with Keefe, Bruyette & Woods, Inc. (“KBW”), as sales agent and/or principal thereunder, and (iv) an open market sale agreement with Compass Point Research & Trading, LLC (“Compass” and together with Jefferies, B. Riley and KBW, the “Sales Agents”), as sales agent and/or principal thereunder.”

FARADAY FUTURE INTELLIGENT ELECTRIC INC. amended Supplemental Agreement (effective 2026-04-30).

“On April 30, 2026, GlobeX AI Hong Kong Holding Limited (“GlobeX”), a special purpose entity controlled by Faraday Future Intelligent Electric Inc. (the “Company”), entered into a Supplemental Agreement (the “Supplemental Agreement”) to the previously executed Engineering Services Agreement, dated February 4, 2026, with its previously announced bridge strategy partner (the Partner”),”

BuzzFeed, Inc. amended Amendment No. 4 to Credit Agreement with the financial institutions party thereto as lenders and Sound Point Agency LLC, as agent (effective 2026-05-07).

“On May 7, 2026, BuzzFeed, Inc. (the “Company”), BuzzFeed Media Enterprises, Inc., a wholly-owned subsidiary of the Company, and certain of the Company’s other domestic and Canadian subsidiaries as borrowers and guarantors, entered into the Amendment No. 4 to Credit Agreement (the “Fourth Amended Credit Agreement”) with the financial institutions party thereto as lenders (the “Lenders”) and Sound Point Agency LLC, as agent for the Lenders.”

Apollo Debt Solutions BDC entered into Registration Rights Agreement with Goldman Sachs & Co. LLC, ING Financial Markets LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC as the representatives of the Initial Purchasers of the Notes (effective 2026-05-07).

“the Fund entered into a Registration Rights Agreement, dated as of May 7, 2026 (the “ Registration Rights Agreement ”), with Goldman Sachs & Co. LLC, ING Financial Markets LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC as the representatives of the Initial Purchasers of the Notes.”

Apollo Debt Solutions BDC entered into Third Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $300 million in aggregate principal amount of its 6.550% notes due 2032 (effective 2025-01-16).

“On May 7, 2026, the Fund issued the New Notes under the Fund’s indenture with U.S. Bank Trust Company, National Association (the “ Trustee ”), dated as of March 21, 2024, and third supplemental indenture, dated as of January 16, 2025 (together, the “ Indenture ”).”

Kodiak AI, Inc. entered into Subscription Agreements with investors named therein, including an affiliate of Ares Management Corporation valued at approximately $100.0 million in gross proceeds (effective 2026-05-07).

“On May 7, 2026, Kodiak AI, Inc. (the “ Company ”) entered into subscription agreements (the “ Subscription Agreements ” and each a “ Subscription Agreement ”) with the investors named therein”

Life Time Group Holdings, Inc. entered into Share Repurchase Agreement with affiliates of Leonard Green & Partners, L.P., TPG Inc. and Partners Group (USA) Inc. valued at aggregate purchase price of approximately $62,705,000 (effective 2026-05-05).

“pursuant to a Share Repurchase Agreement, entered into as of May 5, 2026 (the “Agreement”), by and among the Company and certain of its stockholders, including affiliates of Leonard Green & Partners, L.P., TPG Inc. and Partners Group (USA) Inc.”

Structure Therapeutics Inc. amended Amended and Restated Sales Agreement with Leerink Partners LLC and Cantor Fitzgerald & Co. (effective 2026-05-07).

“On May 7, 2026, Structure Therapeutics Inc. (the “Company”) amended and restated that certain Sales Agreement dated August 6, 2025 (the “Sales Agreement” and as amended and restated, the “Amended and Restated Sales Agreement”) with Leerink Partners LLC and Cantor Fitzgerald & Co. (collectively, the “Sales Agents”), relating to the offer and sale of the Company’s American Depositary Shares (“ADSs”), each representing three ordinary shares, $0.0001 par value per ordinary share.”

HWH International Inc. terminated Termination Agreement with Alset Inc. (effective 2026-05-06).

“Alset Inc. and the Company entered into a Termination Agreement, dated as of May 6, 2026 (the “Termination Agreement”). Under the terms of the Termination Agreement, neither the Company nor Alset Inc. has any further rights or obligations pursuant to the Stock Purchase Agreement.”